Beta 2 antagonism in acute respiratory failure

Beta 2 antagonism in acute respiratory failure

Post hoc analyses from the B-type natriuretic peptide for Acute Shortness of Breath Evaluation (BASEL)-II-ICU study suggest an association between beta-blocker usage at admission and improved mortality in patients treated in the intensive care unit for acute respiratory failure. Although this eviden...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care (London, England) England), 2010, Vol.14 (6), p.1012-1012
Hauptverfasser: Mac Sweeney, Rob, Devereaux, P J, McAuley, Daniel F
Format: Artikel
Sprache:eng
Schlagworte:
Adrenergic beta-Antagonists - administration & dosage
Female
Hospital Mortality - trends
Humans
Intensive Care Units
Male
Respiratory Insufficiency - drug therapy
Respiratory Insufficiency - mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Post hoc analyses from the B-type natriuretic peptide for Acute Shortness of Breath Evaluation (BASEL)-II-ICU study suggest an association between beta-blocker usage at admission and improved mortality in patients treated in the intensive care unit for acute respiratory failure. Although this evidence is encouraging, there is a need for a phase 2 proof-of-concept randomized controlled trial of beta-blocker therapy in patients admitted with acute respiratory failure.
ISSN:1364-8535
1466-609X
DOI:10.1186/cc9359